Clinical Trials
Discover the future of medicine today. Yale Medicine currently offers 692 active clinical trials across our hospitals and care centers, providing our patients with early access to many of the world’s most advanced therapies. Yale Center for Clinical Investigation (YCCI) supports, coordinates, and oversees clinical trials, ensuring the safety of trial volunteers.
For more information about cancer-related trials, call us at 203-785-5702. For all other trials, call 877-978-8343.
A 20-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in Children and Adult Participants with Dravet Syndrome (ARGUS Trial)
- Gender:All Genders
- Age:2 years and older
A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants with Lichen Sclerosus
- Skin/Dermatology
- Gender:Female only
- Age:18 years and older
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Alzheimer's
- Gender:All Genders
- Age:50 years - 85 years
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
- Lung Cancer
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
- Supportive Care
A digital intervention for reducing heavy alcohol use
- Mental Health & Behavioral Research
- Addiction
- Gender:All Genders
- Age:18 years and older
A digital intervention for reducing stimulant drug use
- Mental Health & Behavioral Research
- Addiction
- Gender:All Genders
- Age:18 years and older
A Digital Mindfulness Application for Young Adults with Type 1 Diabetes
- Diabetes
- Mental Health & Behavioral Research
- Endocrine System
A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination With Immuno-Oncology Agents in Subjects With Unresectable Advanced or Metastatic Solid Tumors
- Phase 1 Cancers
- Prostate Cancer
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of SPN-817 in Adults with Focal Onset Seizures
- Brain, Spinal Cord & Nervous System
- Mental Health & Behavioral Research
- Gender:All Genders
- Age:18 years - 70 years
1-10 of 692 Results